Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026 and Aug 2026.
- Largest single sale: $9.2M (31,641 shares) of Ligand Pharmaceuticals Inc on Aug 12, 2026. Filing
- Last sale before this period: Mar 4, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ligand Pharmaceuticals Inc (LGND) | Chief Financial Officer | Nov 7, 2022 | Aug 14, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 12, 2026, Ligand Pharmaceuticals Inc: sold 31,641 shares for $9.2M, under a disclosed plan; 31,641 shares acquired by exercising options. 1 filing: 1
- Jun 30, 2026, Ligand Pharmaceuticals Inc: 17 shares in other transactions. 1 filing: 1
- May 27, 2026, Ligand Pharmaceuticals Inc: 1,736 shares acquired by exercising options. 1 filing: 1
- Mar 11, 2026, Ligand Pharmaceuticals Inc: sold 3,057 shares for $688K, under a disclosed plan; 2,405 shares acquired by exercising options. 1 filing: 1
- Mar 4, 2026, Ligand Pharmaceuticals Inc: sold 13,423 shares for $2.8M, under a disclosed plan; 2,073 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.